Literature DB >> 25845550

Incidence of local in-brain progression after supramarginal resection of cerebral metastases.

Marcel A Kamp1, Marion Rapp, Philipp J Slotty, Bernd Turowski, Hosai Sadat, Maria Smuga, Maxine Dibué-Adjei, Hans-Jakob Steiger, Andrea Szelényi, Michael Sabel.   

Abstract

BACKGROUND: Microsurgical circumferential stripping of intracerebral metastases is often insufficient in achieving local tumor control. Supramarginal resection may improve local tumor control.
METHODS: A retrospective analysis was performed for patients who underwent supramarginal resection of a cerebral metastasis by awake surgery with intraoperative cortical and subcortical stimulation, MEPs, and SSEPs. Supramarginal resection was achieved by circumferential stripping of the metastasis and additional removal of approximately 3 mm of the surrounding tissue. Pre- and postsurgical neurological status was assessed by the NIH Stroke Scale. Permanent deficits were defined by persistence after 3-month observation time.
RESULTS: Supramarginal resection of cerebral metastases in eloquent brain areas was performed in 34 patients with a mean age of 60 years (range, 33-83 years). Five out of 34 patients (14.7%) had a new transient postoperative neurological deficit, which improved within a few days due to supplementary motor area (SMA) syndrome. Five out of 34 patients (14.7%) developed a local in-brain progression and nine patients (26.4%) a distant in-brain progression.
CONCLUSIONS: Supramarginal resection of cerebral metastases in eloquent locations is feasible and safe. Safety might be increased by intraoperative neuromonitoring. The better outcome in the present series may be entirely based on other predictors than extend of surgical resection and not necessarily on the surgical technique applied. However, supramarginal resection was safe and apparently did not lead to worse results than regular surgical techniques. Prospective, controlled, and randomized studies are mandatory to determine the possible benefit of supramarginal resection on local tumor control and overall outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25845550     DOI: 10.1007/s00701-015-2405-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

Review 1.  The impact of cerebral metastases growth pattern on neurosurgical treatment.

Authors:  Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2016-07-09       Impact factor: 3.042

2.  Pre- and early postoperative GFAP serum levels in glioma and brain metastases.

Authors:  Peter Baumgarten; Johanna Quick-Weller; Florian Gessler; Marlies Wagner; Julia Tichy; Marie-Therese Forster; Christian Foerch; Volker Seifert; Michel Mittelbronn; Christian Senft
Journal:  J Neurooncol       Date:  2018-05-24       Impact factor: 4.130

Review 3.  [Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases].

Authors:  A Perrakis; T A Juratli; W Hohenberger; R S Croner; G Schackert
Journal:  Chirurg       Date:  2016-03       Impact factor: 0.955

4.  Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Authors:  Marcel A Kamp; Igor Fischer; Maxine Dibué-Adjei; Christopher Munoz-Bendix; Jan-Frederick Cornelius; Hans-Jakob Steiger; Philipp J Slotty; Bernd Turowski; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2017-12-20       Impact factor: 3.042

5.  Determination of optimal time window for cortical mapping in awake craniotomy: assessment of intraoperative reaction speed.

Authors:  Dziugas Meskelevicius; Artur Schäfer; Jasmin Katharina Weber; Lisa Hegmann; Lisa Haddad; Marcel Alexander Kamp; Bernd Mainzer; Marion Rapp; Hans-Jakob Steiger; Michael Sabel
Journal:  Neurosurg Rev       Date:  2019-03-15       Impact factor: 3.042

6.  Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Authors:  Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

Review 7.  Neurosurgical management of brain metastases.

Authors:  Sherise D Ferguson; Kathryn M Wagner; Sujit S Prabhu; Mary F McAleer; Ian E McCutcheon; Raymond Sawaya
Journal:  Clin Exp Metastasis       Date:  2017-09-30       Impact factor: 5.150

8.  T-Cell Densities in Brain Metastases Are Associated with Patient Survival Times and Diffusion Tensor MRI Changes.

Authors:  Rasheed Zakaria; Angela Platt-Higgins; Nitika Rathi; Mark Radon; Sumit Das; Kumar Das; Maneesh Bhojak; Andrew Brodbelt; Emmanuel Chavredakis; Michael D Jenkinson; Philip S Rudland
Journal:  Cancer Res       Date:  2017-12-06       Impact factor: 12.701

9.  Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Anna Maria Ascolese; Giulia Maggi; Marco Riva; Giovanna Masci; Giuseppe D'Agostino; Giovanna Finocchiaro; Armando Santoro; Lorenzo Bello; Marta Scorsetti
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

10.  5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression.

Authors:  Marcel A Kamp; Igor Fischer; Julia Bühner; Bernd Turowski; Jan Frederick Cornelius; Hans-Jakob Steiger; Marion Rapp; Philipp J Slotty; Michael Sabel
Journal:  Oncotarget       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.